ibi351
Showing 1 - 4 of 4
Healthy Subjects Trial in Suzhou (IBI351, Esomeprazole)
Not yet recruiting
- Healthy Subjects
- IBI351
- Esomeprazole
-
Suzhou, Jiangsu, Chinathe First Affiliated Hospital of Suzhou University
Jan 13, 2023
Healthy Subjects Trial in Suzhou (Itraconazole, IBI351, Dextromethorphan)
Not yet recruiting
- Healthy Subjects
- Itraconazole
- +2 more
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Suzhou University
Jan 25, 2023
Colorectal Cancer Trial in Hangzhou (IBI351)
Not yet recruiting
- Colorectal Cancer
- IBI351
-
Hangzhou, Zhejiang, ChinaThe Second Affiliated Hospital of Zhejiang University School of
Aug 9, 2022
Advanced NSCLC Trial in Jilin (pemetrexed, Cetuximab, cis-platinum)
Not yet recruiting
- Advanced Non-Small Cell Lung Cancer
- pemetrexed
- +5 more
-
Jilin, Changchun, ChinaJilin Province Cancer Hospital
Aug 15, 2022